A whistleblower document submitted to Green Economy News on April 4 alleges that four health food and beauty device brands registered under different representatives are actually operated by a single individual, with repeated issues of origin misrepresentation and drug-misleading advertising. The report raises red flags for overseas buyers sourcing from South Korea, as it suggests potential regulatory evasion and supply-chain opacity.
Alleged common operator behind four brands
The document identifies four entities: Infuragen Bio (seller of diet food 'Wego Pro'), Nextrip (a beauty device seller), Ire Company (operator of children's health brand 'I Kids Lab'), and Texas Cure (seller of 'Yondube Ddukjjanku' cookies). According to the whistleblower and corporate registry records, a man named Shin Sung-min appears as a founding insider in two of the three incorporated entities—Nextrip and Surfer's Paradise Seoul (renamed Infuragen Bio). Shin stepped down as inside director of Infuragen Bio on March 17, 2025, and Lee Seung-eun took over the same day. The company changed its name and business purpose from cosmetics to health functional foods within a month.
Shared directors and factory links
A second individual, Byun Kang-deuk, served as auditor for both Nextrip and Surfer's Paradise Seoul, resigning exactly four days after each appointment. Byun later registered Ire Company as a sole proprietorship on December 18, 2024, launching I Kids Lab. The manufacturing site for both Wego Pro and I Kids Lab products is listed as Bobusang Biopharm in Iksan, North Jeolla Province, sharing the same 11-digit manufacturing license prefix (20220683473).
Yondube Ddukjjanku origin discrepancy
Texas Cure, established September 16, 2025, with capital of 10 million won and a single director, Choi Jin-young, operates from a shared office in Gangnam-gu, Seoul. The whistleblower identifies Choi as Shin's cousin. Texas Cure sells 'Yondube Ddukjjanku,' which its sales page claims uses 100% kadaif imported directly from the origin country. However, Korea's Ministry of Food and Drug Safety import records show the product's country of manufacture as China, with no kadaif listed among declared ingredients.
Regulatory and channel signals
Korea's Pharmaceutical Association has publicly warned consumers about Wego Pro, a solid tea-type food marketed to resemble the obesity drug Wegovy. The overlapping corporate structures, rapid director changes, and shared manufacturing facilities suggest a pattern that could complicate due diligence for overseas distributors. Importers should verify product origin declarations against official import records and check for any regulatory warnings before placing orders.
Sourcing context
For B2B buyers in medical aesthetics and health food, this case highlights the importance of auditing not just product claims but also the corporate and manufacturing links behind brands. The inability to access shareholder registers or inter-company financial records for unlisted firms means that independent verification of supply-chain integrity is critical. Distributors should request full product registration documents and manufacturing licenses directly from suppliers.
Source: Read the original report | Published: June 08, 2026